Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-08-20
1993-06-08
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 514530, 530330, 530331, A61K 31405, C07D20920, C07D40312
Patent
active
052179575
ABSTRACT:
The invention concerns cholecystokinin (CCK) antagonists useful in the treatment major and minor forms of depression. CCK-B, -A, and mixed -A and -B antagonists are useful. Especially useful are CCK.sub.B antagonists such as CI-988.
REFERENCES:
patent: 4791215 (1988-12-01), Rovati et al.
patent: 4820834 (1989-04-01), Evans et al.
patent: 5084479 (1992-01-01), Woodruff
Berkow, editor "The Merck Manual of Diagnosis and Therapy", Fourteenth Edition, Published by Merck Sharp & Dohme Research Laboratories division of Merck & Co., Inc. Rahway, N.J., 1982, pp. 1448-1463.
Yu et al., "Quinazolinone Cholecystokinin-B-Receptor Ligands," J. Med. Chem. 1991, 34, pp. 1505-1508.
Bradwejn et al., "Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic Disorder," Can. J. Psychiatry vol. 35, Feb. 1990, pp. 83-85.
de Montigny, "Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy Volunteers," ARCH, GEN PSYCHIATRY, vol. 46, Jun. 1989, pp. 511-517.
Annu. Rev. Pharmacol. Toxicol., 1991, 31:469-501 "Cholecystokinin Antagonists", G. N. Woodruff et al.
Proc. Natl. Acad. Sci. USA, vol. 87, pp. 6728-6732 Sep. 1990, "Development of a Class . . . Cholecystokinin . . . ", J. Hughes et al.
Proc. Natl. Acad. Sci. USA, vol. 88, pp. 1130-1133, Feb. 1991, "Evidence for . . . Cholecystokinin B . . . " L. Singh et al.
Nature vol. 266, 21 Apr. 1977, pp. 730-732, "Depression: A New Animal Model . . . ", R. D. Porsolt, et al.
Anderson Elizabeth M.
Griffin Ronald W.
Warner-Lambert & Company
LandOfFree
Cholecystokinin antagonists useful for treating depression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholecystokinin antagonists useful for treating depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholecystokinin antagonists useful for treating depression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1934142